Otrizol-DF 0,1% 10ml nasal spray metered menthol and CG.

The instruction for medical use of Otrizol-DF medicine the Trade name of Otrizol-DF the International unlicensed name Xylomethazolinum Dosage Form Spray of Nasal 0.1% with menthol and an eucalyptus, 10 ml Structure of 100 ml of drug contains active agent - xylomethazolinum a hydrochloride of 0.1 g, excipients: dihydrophosphate sodium a dihydrate, phosphate dinatrium dodecahydrate, sodium chloride, a benzalkoniya chloride, dinatrium edetat, left menthol, cineole, sorbitol, liquid crystallizing 70%, castor oil, polioksit hydrogenated (RH 40 cremophore), water cleaned. The description Opalescent solution of white color with a smell of menthol and an eucalyptus. Pharmacotherapeutic group Nasal drugs. Antikongestanta and other nasal drugs for topical administration. Sympathomimetics. Xylomethazolinum the ATX R01AA07 Code the Pharmacological Pharmacokinetics At properties topical administration in the recommended doses drug is practically not absorbed, concentration in plasma are so small that they cannot be determined by modern analytical methods. The pharmacodynamics of Otrizol-DF belongs to an alpha adrenomimetikam from group of derivatives of imidazoline. In low concentration works on α2-адренорецепторы, in high concentrations has effect on α1-адренорецепторы. At topical administration causes narrowing of blood vessels of a mucous membrane of a nose, reduces a blood stream in venous sine, eliminating, thus, hypostasis and hyperaemia of a mucous membrane of a nose, reduces amount of the separated secretion, restores passability of the nasal courses, facilitates nasal breath in rhinitises. The left menthol and an eucalyptus which are contained in drug have the cooling effect on a mucous membrane of a nose. In therapeutic concentration does not irritate mucous, does not cause hyperaemia. Action comes in 5 - 10 minutes, and remains for 6-8 hours, the spasm of blood vessels remains till 8-10 o'clock. Indications - acute respiratory diseases with the phenomena of rhinitis (cold) - acute allergic rhinitis (hay fever, a pollinosis) - sinusitis - an eustachitis - average otitis (as a part of combination therapy — for reduction of hypostasis of a mucous nasopharynx) - training of the patient for diagnostic manipulations in the nasal courses the Route of administration and Intranazalno's doses. Adults and children are more senior than 12 years: on 1 injection in each nasal course with an interval of 8-10 hours. It is not necessary to apply more than 3 times a day and also it is not necessary to apply more than 10 days. Side effects often: - a headache - at frequent or prolonged use the irritation or dryness mucous a nose, an atrophy mucous a nose, burning, sneezing, dependence, hypersecretion, chronic rhinitis seldom is possible: - heartbeat, tachycardia, arrhythmias, increase in arterial blood pressure - nausea - insomnia - allergic reaction (Quincke's edema, urticaria, an itching) - a depression (at prolonged use of high doses) - a rhinedema - a disorder of vision is very rare: - excitement - fatigue, drowsiness, block of the Contraindication - hypersensitivity to xylomethazolinum or any other component of drug - atrophic rhinitis - closed-angle glaucoma - surgical interventions on a meninx (in the anamnesis) - a hyperthyroidism - the profound atherosclerosis - arterial hypertension - tachycardia - a serious illness of eyes - pregnancy, the lactation period - a concomitant use of inhibitors of a monoaminooxidase and the period up to 14 days after the end of their use - children's age up to 12 years with care: - diabetes - a porphyria - a prostate hyperplasia - a pheochromocytoma Medicinal interaction Is incompatible with MAO inhibitors and tricyclic antidepressants. Special instructions it is not necessary to exceed independently recommended doses and to use drug in the continuous mode more than 10 days. Long (more than 10 days) or excessive use of drug can cause effect of ricochet (medicamentous rhinitis). To apply with care in the coronary heart disease (CHD). The children's age Is contraindicated at children's age up to 12 years. Features of influence of drug on ability to run the vehicle or potentially dangerous mechanisms Drug in the recommended doses does not affect ability to run motor transport or potentially dangerous mechanisms. Overdose Symptoms: feeling of alarm, excitement, hallucinations and spasms, a hypothermia, a lethargy, drowsiness, a coma, a miosis, a mydriasis, the increased sweating, fever, pallor of integuments, cyanosis, nausea and vomiting, tachycardia, bradycardia, cardiac arrhythmia, cardiac arrest, palpitation, hypertensia, shocklike hypotonia, a fluid lungs, respiratory depression and an apnoea, mental disorders. At children after overdose the symptoms from central nervous system including spasms, a coma, bradycardia, an apnoea and hypertensia which can pass into hypotonia develop generally. The clinical picture of intoxication can be greased since phases of stimulation of central nervous system alternate with phases of oppression of central nervous system. Treatment: immediately appoint activated carbon (adsorbent), sodium sulfate (depletive) or gastric lavage. In a lowering of arterial pressure appoint non-selective alpha blockers. Use of vazopressor is contraindicated. If necessary carry out febrifugal, anticonvulsant therapy and artificial ventilation of the lungs. The form of release and packing On 10 ml of drug place in brown plastic bottles with a raspylitelny nozzle and a protective cap. On 1 bottle together with the instruction for medical use in the state and Russian languages place in a pack from cardboard. To Store storage conditions in the place protected from light, at a temperature not above 25 °C. To store out of children's reach! 2 years 6 months not to apply a period of storage after an expiration date. Prescription status Without prescription DOSFARM LLP Producer, Kazakhstan, 050034, Almaty, Chaplygin St., 3 the Owner of the registration certificate of DOSFARM LLP, Kazakhstan, 050034, Almaty, Chaplygin St., 3 the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of the products responsible for post-registration observation of safety medicinal sredstvatoo DOSFARM, Republic of Kazakhstan, Almaty, Chaplygin St., 3